4-Methyl-2-[1-(tert-butoxycarbonyl)piperid-4-yl]1,3-thiazole-5-carboxylic acid, 10g

2-(2-Chlorophenyl)propan-2-ol, 97%, 1g

(4R)-2,2-Dimethyl-4-thiazolidinecarboxylic Acid>98.0%(T)5g

(9H-fluoren-9-yl)methyl N-(2-((4-(4-(3-bromo-4-fluorophenyl)-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1,2,5-oxadiazol-3-yl)amino)ethyl)sulfamoylcarbamate, 98%, 250mg

2-(1-(4-Methoxyphenyl)vinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

4,5-DICHLORO-1,3-DIOXOLAN-2-ONE, 97.0%, 100mg

2-Methyl-4-trimethylsilyl-1-buten-3-yne, 97%, 5g

MOZAVAPTAN, 99%, 10mg

7-Bromo-4,4-dimethyl-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 50mg

5-(4-aminophenyl)-1,3,4-oxadiazole-2-thiol, 97.0%, 25g

3-Hydroxy-5-methylpicolinic acid, 98%, 100mg

4-(2-Bromobenzoyl)morpholine, 98.0%, 5g

Báscula analítica y de precisión serie Entris® II Modelos con ajuste interno, calibrada de fábrica, 0,001 g, 220 g, BCE223i-1CEU (W)